Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Cytochrome P450 19A1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Dictyostelium discoideum | cytochrome P450 family protein | Cytochrome P450 19A1 | 508 aa | 473 aa | 18.8 % |
Loa Loa (eye worm) | cytochrome P450 family protein | Cytochrome P450 19A1 | 508 aa | 450 aa | 21.1 % |
Dictyostelium discoideum | cytochrome P450 family protein | Cytochrome P450 19A1 | 508 aa | 465 aa | 21.5 % |
Drosophila melanogaster | Cytochrome P450-4d1 | Cytochrome P450 19A1 | 508 aa | 464 aa | 24.6 % |
Brugia malayi | Cytochrome P450 family protein | Cytochrome P450 19A1 | 508 aa | 448 aa | 20.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | thymidylate kinase-like protein | 0.0297203 | 1 | 1 |
Echinococcus multilocularis | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Plasmodium falciparum | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Mycobacterium leprae | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) | 0.0297203 | 1 | 0.5 |
Onchocerca volvulus | Putative thymidylate kinase | 0.0297203 | 1 | 0.5 |
Echinococcus granulosus | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0297203 | 1 | 1 |
Schistosoma mansoni | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Toxoplasma gondii | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0297203 | 1 | 1 |
Plasmodium vivax | thymidylate kinase, putative | 0.0297203 | 1 | 0.5 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0297203 | 1 | 1 |
Giardia lamblia | CDC8 | 0.0297203 | 1 | 1 |
Schistosoma mansoni | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Loa Loa (eye worm) | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Leishmania major | thymidine kinase, putative | 0.0215231 | 0.542714 | 0.542714 |
Schistosoma mansoni | hypothetical protein | 0.0297203 | 1 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0297203 | 1 | 1 |
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | 0.0297203 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Treponema pallidum | thymidylate kinase (tmk) | 0.0297203 | 1 | 0.5 |
Brugia malayi | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0297203 | 1 | 1 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.0297203 | 1 | 1 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0215231 | 0.542714 | 0.542714 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0297203 | 1 | 1 |
Chlamydia trachomatis | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Mycobacterium ulcerans | thymidylate kinase | 0.0297203 | 1 | 0.5 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0215231 | 0.542714 | 0.542714 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 0.066 uM | In vitro inhibition of cytochrome P450 19A1 by rat ovarian microsomes incubated with [3H]-androstenedione and NADPH-generating system. | ChEMBL. | 3612685 |
EC50 (binding) | = 0.066 uM | In vitro inhibition of cytochrome P450 19A1 by rat ovarian microsomes incubated with [3H]-androstenedione and NADPH-generating system. | ChEMBL. | 3612685 |
IC50 (functional) | = 0.197 uM | Antitrypanosomal activity against trypomastigotes of Trypanosoma cruzi Tulahuen expressing the beta- galactosidase gene infected rat L6 cells after 96 hrs | ChEMBL. | 22536986 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Trypanosoma cruzi | ChEMBL23 | 22536986 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.